NPCE · NeuroPace Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-24 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on June 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
335 |
| 2026-06-19 | Geiger Uri |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
789 |
| 2026-06-19 | Fischer Frank M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
1,467 |
| 2026-06-19 | Kumar Rakhi |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
989 |
| 2026-06-05 | Kumar Rakhi |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (Right to Buy)
|
5,368 |
| 2026-06-05 | Huennekens R Scott |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (Right to Buy)
|
5,368 |
| 2026-06-05 | Fischer Frank M |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (Right to Buy)
|
5,368 |
| 2026-06-05 | Andrade Lisa |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (Right to Buy)
|
5,368 |
| 2026-06-05 | Kumar Rakhi |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. |
Common Stock
|
2,890 |
| 2026-06-05 | Fischer Frank M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. |
Common Stock
|
2,890 |
| 2026-06-05 | Andrade Lisa |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. |
Common Stock
|
2,890 |
| 2026-06-05 | Geiger Uri |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. |
Common Stock
|
2,890 |
| 2026-06-05 | Ryan Renee |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. |
Common Stock
|
2,890 |
| 2026-06-05 | Huennekens R Scott |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date. |
Common Stock
|
2,890 |
| 2026-06-05 | Ryan Renee |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (Right to Buy)
|
5,368 |
| 2026-06-05 | Geiger Uri |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date. |
Stock Option (Right to Buy)
|
5,368 |
| 2026-06-03 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on June 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,255 |
| 2026-05-27 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,126 |
| 2026-05-27 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on May 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
358 |
| 2026-05-15 | Williams Patrick F. |
Chief Financial Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. |
Stock Option (Right to Buy)
|
44,800 |
| 2026-05-15 | Williams Patrick F. |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
Common Stock
|
16,820 |
| 2026-05-15 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
Common Stock
|
5,460 |
| 2026-05-15 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. |
Stock Option (Right to Buy)
|
14,550 |
| 2026-05-15 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option vest on May 15, 2027. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. |
Stock Option (Right to Buy)
|
122,190 |
| 2026-05-15 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Award↑
Filing footnotes — Common Stock (Direct)
Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on May 15, 2027 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
Common Stock
|
45,880 |
| 2026-03-24 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on March 24, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,341 |
| 2026-03-20 | Geiger Uri |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
913 |
| 2026-03-20 | Fischer Frank M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
1,826 |
| 2026-03-20 | Kumar Rakhi |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
1,153 |
| 2026-03-20 | LACOB JOSEPH |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
865 |
| 2026-03-03 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
5,023 |
| 2026-03-03 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,340 |
| 2026-02-27 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,126 |
| 2026-02-27 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on February 27, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
358 |
| 2026-02-20 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on February 20, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
3,412 |
| 2025-12-19 | Geiger Uri |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
715 |
| 2025-12-19 | LACOB JOSEPH |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
678 |
| 2025-12-19 | Kumar Rakhi |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
904 |
| 2025-12-19 | Fischer Frank M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
1,431 |
| 2025-12-15 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form. |
Common Stock
|
25,000 |
| 2025-12-03 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on December 3, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,338 |
| 2025-11-27 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on November 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
357 |
| 2025-11-27 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on November 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,126 |
| 2025-11-20 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on November 20, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
3,051 |
| 2025-09-19 | Kumar Rakhi |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
1,509 |
| 2025-09-19 | Geiger Uri |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
1,194 |
| 2025-09-19 | Fischer Frank M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
2,389 |
| 2025-09-19 | LACOB JOSEPH |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. |
Common Stock
|
1,131 |
| 2025-09-03 | Morrell Martha |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on September 3, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,337 |
| 2025-08-27 | Becker Joel |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares withheld by the Issuer on August 27, 2025 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award. |
Common Stock
|
1,126 |